SEC Form 4 · accession 0001179110-18-004290
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephany Verstraete
Officer — Chief Marketing Officer
Period of report
Mar 12, 2018
Accepted (ET)
Mar 14, 2018 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 12, 2018 | M | 1,925 | — | A | 1,925 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3,F2 | — | Mar 12, 2018 | M | 1,925 | D | — | — | Common Stock | 1,925 | 5,775 | D |
Explanation of responses
- F1Restricted stock units convert to common stock on a one-for-one basis.
- F2On May 25, 2017, the reporting person was granted 7,700 restricted stock units, vesting in four equal annual installments beginning on March 3, 2018.
- F3Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.